Home
>
National Drug Code (NDC)
>
Kaletra
Kaletra - 0074-0522-60 - (Lopinavir and Ritonavir)
Drug Information of Kaletra
| Product NDC: | 0074-0522 |
| Proprietary Name: | Kaletra |
| Non Proprietary Name: | Lopinavir and Ritonavir |
| Active Ingredient(s): | 100; 25 mg/1; mg/1 & nbsp; Lopinavir and Ritonavir |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Kaletra
| Product NDC: | 0074-0522 |
| Labeler Name: | AbbVie Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021906 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20100618 |
Package Information of Kaletra
| Package NDC: | 0074-0522-60 |
| Package Description: | 60 TABLET, FILM COATED in 1 BOTTLE (0074-0522-60) |
NDC Information of Kaletra
| NDC Code | 0074-0522-60 |
| Proprietary Name | Kaletra |
| Package Description | 60 TABLET, FILM COATED in 1 BOTTLE (0074-0522-60) |
| Product NDC | 0074-0522 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Lopinavir and Ritonavir |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20100618 |
| Marketing Category Name | NDA |
| Labeler Name | AbbVie Inc. |
| Substance Name | LOPINAVIR; RITONAVIR |
| Strength Number | 100; 25 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes | HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC] |
